title: Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.
abstract: Current L1 virus-like particle (VLP) vaccines provide type-restricted protection against a small subset of the human papillomavirus (HPV) genotypes associated with cervical cancer, necessitating continued cytologic screening of vaccinees. Cervical cancer is most problematic in countries that lack the resources for screening or highly multivalent HPV VLP vaccines, suggesting the need for a low-cost, broadly protective vaccinogen. Here, N-terminal L2 polypeptides comprising residues 1 to 88 or 11 to 200 derived from HPV16, bovine papillomavirus type 1 (BPV1), or cottontail rabbit papillomavirus (CRPV) were produced in bacteria. Rabbits were immunized with these N-terminal L2 polypeptides and concurrently challenged with CRPV and rabbit oral papillomavirus (ROPV). Vaccination with either N-terminal L2 polypeptides of CRPV effectively protected rabbits from CRPV challenge but not from papillomas induced by cutaneous challenge with CRPV genomic DNA. Furthermore, papillomas induced by CRPV genomic DNA deficient for L2 expression grew at the same rate as those induced by wild-type CRPV genomic DNA, further suggesting that the L2 polypeptide vaccines lack therapeutic activity. Neutralizing serum antibody titers of >15 correlated with protection (P < 0.001), a finding consistent with neutralizing antibody-mediated protection. Surprisingly, a remarkable degree of protection against heterologous papillomavirus types was observed after vaccination with N-terminal L2 polypeptides. Notably, vaccination with HPV16 L2 11-200 protected against cutaneous and mucosal challenge with CRPV and ROPV, respectively, papillomaviruses that are evolutionarily divergent from HPV16. Further, vaccination with HPV16 L2 11-200 generates broadly cross-neutralizing serum antibody, suggesting the potential of L2 as a second-generation preventive HPV vaccine antigen.
authors: Department of Pathology, Johns Hopkins School of Medicine, 1550 Orleans Street, Baltimore, MD 21231, USA.
authors: Ratish
authors: R
authors: Gambhira
authors: Subhashini
authors: S
authors: Jagu
authors: Balasubramanyam
authors: B
authors: Karanam
authors: Patti E
authors: PE
authors: Gravitt
authors: Timothy D
authors: TD
authors: Culp
authors: Neil D
authors: ND
authors: Christensen
authors: Richard B S
authors: RB
authors: Roden
mesh_terms: D000818:Animals; D036022:Capsid Proteins / Q000737:chemistry* / Q000378:metabolism; D004279:DNA, Viral / Q000235:genetics / Q000378:metabolism; D005260:Female; D005838:Genotype; D009500:Neutralization Tests; D009856:Oncogene Proteins, Viral / Q000737:chemistry* / Q000378:metabolism; D010212:Papilloma / Q000517:prevention & control / Q000821:virology; D027383:Papillomaviridae / Q000378:metabolism; D010455:Peptides / Q000737:chemistry; D017434:Protein Structure, Tertiary; D011817:Rabbits; D012867:Skin / Q000821:virology; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control / Q000821:virology; D014765:Viral Vaccines / Q000737:chemistry*
chemical_list: D036022:Capsid Proteins; D004279:DNA, Viral; C063316:L2 protein, Human papillomavirus type 16; D009856:Oncogene Proteins, Viral; D010455:Peptides; D014765:Viral Vaccines
references: J Virol. 2001 Mar;75(5):2331-6
references: 11160736
references: Virology. 2005 Jul 5;337(2):365-72
references: 15885736
references: J Virol. 2002 Oct;76(19):9798-805
references: 12208958
references: N Engl J Med. 2002 Nov 21;347(21):1645-51
references: 12444178
references: J Virol. 2003 Mar;77(6):3531-41
references: 12610128
references: J Biol Chem. 2003 Apr 4;278(14):12546-53
references: 12560332
references: Virology. 2004 Apr 10;321(2):205-16
references: 15051381
references: Obstet Gynecol. 2006 Jan;107(1):18-27
references: 16394035
references: Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1522-7
references: 16432208
references: Lancet. 2006 Apr 15;367(9518):1247-55
references: 16631880
references: Vaccine. 2006 Jun 29;24(26):5516-25
references: 16725236
references: Nat Rev Cancer. 2006 Oct;6(10):753-63
references: 16990853
references: Cancer Res. 2006 Dec 1;66(23):11120-4
references: 17145854
references: Lancet. 2007 Jun 30;369(9580):2161-70
references: 17602732
references: Viral Immunol. 2006 Summer;19(3):492-507
references: 16987067
references: Virology. 2000 May 10;270(2):254-7
references: 10792983
references: Virology. 2004 Jun 20;324(1):17-27
references: 15183049
references: Int J Cancer. 2004 Aug 20;111(2):278-85
references: 15197783
references: J Virol. 1990 Jul;64(7):3151-6
references: 1693698
references: Virology. 1991 Apr;181(2):572-9
references: 1707567
references: Virology. 1992 Apr;187(2):612-9
references: 1312271
references: Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12180-4
references: 1334560
references: J Virol. 1993 Apr;67(4):1936-44
references: 8383219
references: J Gen Virol. 1994 Sep;75 ( Pt 9):2445-9
references: 8077946
references: J Virol. 1995 Jun;69(6):3959-63
references: 7745754
references: Virology. 1995 Aug 1;211(1):204-8
references: 7544045
references: Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11553-7
references: 8524802
references: J Virol. 1996 May;70(5):3298-301
references: 8627814
references: J Virol. 1996 Sep;70(9):5875-83
references: 8709207
references: J Gen Virol. 1996 Aug;77 ( Pt 8):1793-8
references: 8760428
references: J Gen Virol. 1996 Jul;77 ( Pt 7):1577-83
references: 8758002
references: Virology. 1996 Oct 15;224(2):477-86
references: 8874508
references: Clin Dermatol. 1997 Mar-Apr;15(2):275-83
references: 9167911
references: Virology. 1997 Aug 4;234(2):261-6
references: 9268157
references: Res Vet Sci. 1997 May-Jun;62(3):289-91
references: 9300551
references: J Virol. 1998 Jul;72(7):6151-4
references: 9621080
references: J Virol. 1999 Jul;73(7):6188-90
references: 10364381
references: J Pathol. 1999 Sep;189(1):12-9
references: 10451482
references: J Virol. 1999 Nov;73(11):9609-13
references: 10516071
references: Lancet. 2004 Nov 13-19;364(9447):1757-65
references: 15541448
references: Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):283-8
references: 15668510
references: Lancet Oncol. 2005 May;6(5):271-8
references: 15863374
references: Vaccine. 2001 Jan 8;19(11-12):1496-502
references: 11163673